A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein (a), according to late-breaking science presented today at the ...

Both Kadlec Regional Medical Center and Richland Fire and EMS have been recognized and awarded by the aemrican heart ...

Having a higher level of cardiorespiratory fitness reduced the risk for cognitive decline and Alzheimer’s, even in people at ...

The American Lung Association released its annual “State of Lung Cancer” report that ranks lung cancer response by state.

It may be the most wonderful time of the year, but it’s also the most stressful. Follow these expert tips for staying ...

Stroke was the fourth leading cause of death in the U.S. in 2023, according to the Centers for Disease Control and Prevention ...

The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...

On Monday, Silence Therapeutics plc (NASDAQ: SLN) presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran in atherosclerotic cardiovascular disease (ASCVD) patients with high ...

Existing research has tied sedentary behavior to a slew of health problems in both children and adults, from obesity and poor ...

While having HDL levels above 60 mgdL is often seen as a sign of good health it’s not a standalone indicator Read ahead to ...

Zerlasiran was found to be well tolerated and no significant safety concerns were observed. Credit: Good dreams - Studio via ...